https://www.healthcaremea.com/2026/05/07/bayer-to-acquire-perfuse-therapeutics-in-us2-45b-deal-to-strengthen-its-ophthalmology-pipeline/
Bayer to acquire Perfuse Therapeutics in US$2.45B deal to strengthen its ophthalmology pipeline |...
May 7, 2026 - The acquisition comes as Bayer seeks to reinforce its position in ophthalmology amid growing biosimilar competition facing Eylea, which it co-developed with...
bayeracquireperfusetherapeutics45b
https://briefpharma.com/bayer-acquires-perfuse-for-2-45b/
Bayer Acquires Perfuse for $2.45B
May 6, 2026 - Bayer to buy Perfuse Therapeutics for $300M upfront + $2.15B milestones for Phase 2 PER-001 in glaucoma and diabetic retinopathy.
bayeracquiresperfuse45b
https://www.pharmexec.com/view/roundup-bayer-acquire-perfuse-therapeutics-madrigal-licensing-agreement-aro-pnpla3
Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for...
May 6, 2026 - Madrigal and Bayer strike billion-dollar deals to expand pipelines, with Madrigal licensing a PNPLA3-targeting siRNA for MASH and Bayer acquiring Perfuse...
m a
https://fd.nl/bedrijfsleven/1595743/bayer-koopt-oogmedicijnenbedrijf-perfuse-voor-maximaal-2-45-mrd
Bayer koopt oogmedicijnenbedrijf Perfuse voor maximaal $2,45 mrd
Het Duitse Bayer koopt Perfuse Therapeutics, dat een veelbelovend oogmedicijn ontwikkelt.
bayerperfusevoormrd
https://european-biotechnology.com/latest-news/for-several-billions-bayer-adds-perfuse-therapeutics-to-portfolio-of-eye-therapies/
For several billions: Bayer adds Perfuse Therapeutics to portfolio of eye therapies - European...
Bayer AG is strengthening its ophthalmology portfolio with the acquisition of Perfuse Therapeutics for up to $2.45bn. The focus is on a Phase II candidate for...
to portfolio
https://www.law360.co.uk/articles/2474121
Baker McKenzie-Led Bayer To Buy Perfuse For Up To $2.45B - Law360 UK
Pharmaceutical giant Bayer AG said Wednesday that it will buy Perfuse Therapeutics, a U.S. biopharma company, for up to $2.45 billion as it seeks a treatment...
baker mckenzieto buylaw360 uk
https://www.bizportal.co.il/BizTech/news/article/20031580
באייר, חברת התרופות העולמית רוכשת את Perfuse האמריקנית
May 7, 2026 - Perfuse היא חברת ביוטכנולוגיה אמריקנית המפתחת טיפולים למחלות עיניים והעסקה לרכישתה כוללת תשלום מיידי של 300 מיליון דולר כאשר העסקה כולה צפויה לעמוד על שווי של...
perfuse